Small Business Resources, Business Advice and Forms from AllBusiness.com

U.S. MedSys Corp. Names Nancy Pomposello as Director of Marketing.

DENVER -- U.S. MedSys Corp. (OTCBB: UMSY) announced today that it has appointed Nancy Pomposello to take the newly created position of Director of Marketing effective October 1, 2004. The appointment is subject to the finalization of details of Ms. Pomposello's contract.

Ms. Pomposello

brings close to twenty-five years of marketing success to the UMSY marketing program. Over the past ten years Ms. Pomposello has held such positions as Director of Provider Relations for Magna Care/Magnet PPO and recruited over 15,000 physicians and supporting ancillary services for that network in a twenty-four-month period. She also held the position of Director of Health and Welfare Sales, Corporate and Major Accounts Division, of Blue Cross and Blue Shield of New Jersey. While there she developed and managed business representing a fifty percent market share of Taft-Hartley Health and Welfare Funds in the state of New Jersey, comprising 170,000 lives and yielding $200 million in premium income.

Most recently Ms. Pomposello held the position of New Business Manager with CIGNA. She was responsible for sales, marketing and management of Taft-Hartley fund accounts in northern New Jersey and the New York Metropolitan area. Her responsibilities included sales and maintenance of CIGNA's health insurance product line including medical, pharmaceutical, behavioral health and dental coverage to union groups such as metro ILA, various HERE locals, TWU and various locals of IATSE and the entertainment industry. As a result of her management, 90,000 new lives were added to CIGNA's new market segment for that business.

Commenting on her new position, Ms. Pomposello said: "I feel very fortunate to be managing the marketing program at U.S. MedSys Corp. The healthcare market is growing and changing at an increasing rate, especially in the disease-management area. After considering the many business opportunities presented to me, UMSY's business plan is very well thought out considering the direction healthcare is taking. This, combined with the continued development of a strong management team, gives me great confidence in the future success of the company. To lead the marketing effort of an organization whose business model is complementary to my business experience enables me to be a significant contributor to the growth of this exciting company."

Peter Futro, President of UMSY commented: "We are very excited by this new addition to our management team and the anticipated contribution to the success of UMSY that Ms. Pomposello brings with her. We feel very confident that her competence and experience in healthcare and time-tested business acumen will contribute greatly to the continued growth of our company. The addition of Ms. Pomposello to the UMSY team is yet another example of strengthening our company by bringing onboard the best possible individuals in the marketplace."

U.S. MedSys Corp. is a network development, marketing and distribution organization which provides medical technology and support services to the healthcare industry. U.S. MedSys Corp. is focusing on its core competencies in network development and marketing. As well as U.S. MedSys Corp., the UMSY business network consists of PMC/Foot Care, LLC, the largest podiatric network in the U.S.; Global Medical Direct, LLC (GMD), a network provider of sales, marketing and distribution of self-management products and services to patients with diabetes; contractual relationships with Practice Management Corp., a third-party administrator; and New York Home Health Care Equipment, which provides comprehensive services to hospitals, long-term care facilities and home-care patients in the metropolitan New York and New Jersey area. The company outsources other functions, such as manufacturing, related engineering and product development. For more information see www.usmedsyscorp.com.

This press release contains "forward-looking statements" within the meaning of Section 27A of the 1933 Securities Act and Section 21E of the 1934 Securities Exchange Act. Actual results could differ materially, as the result of such factors as competition in the markets for the company's products and services and the ability of the company to execute its plans. By making these forward-looking statements, the company can give no assurances that transactions described in this press release will be successfully completed, and undertakes no obligation to update these statements for revisions or changes after the date of this press release.

In addition, make sure to read these articles: